
Avenue Therapeutics Investor Relations Material
Latest events

AGM 2024
Avenue Therapeutics

Q1 2025
14 May, 2025

Q4 2024
31 Mar, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Avenue Therapeutics Inc
Access all reports
Avenue Therapeutics Inc is a U.S.-based specialty pharmaceutical company focused on the development and commercialization of treatments for acute and chronic pain. The company operates in the late-stage clinical development space, advancing non-opioid and opioid pain management therapies. Its strategy includes partnering for regulatory approval and market entry. The company is headquartered in Miami, Florida, and its shares are listed on the NASDAQ.